Specialized pro-resolving lipid mediators (SPMs) derived from omega-3 EPA and DHA actively orchestrate muscle recovery by limiting neutrophil infiltration, promoting cellular cleanup, and switching macrophages from inflammatory to repair modes. Exercise naturally triggers these SPM circuits, with chronic training priming enhanced resolution capacity. The research reveals that lipid mediator class switching is intrinsically required for muscle stem cell differentiation—a previously unknown mechanistic requirement.
This finding fundamentally reframes muscle recovery from passive inflammation dissipation to active resolution programming. The discovery carries significant implications for athletic recovery, injury rehabilitation, and age-related muscle loss. NSAIDs emerge as potential recovery inhibitors by blocking endogenous SPM production and impairing satellite cell activity—contradicting widespread use for exercise soreness. The identification of "resolution deficit" as a driver of sarcopenia and muscular dystrophy opens therapeutic avenues beyond anti-inflammatory approaches. Rather than simply suppressing inflammation, targeting SPM pathways could directly enhance stem cell-mediated regeneration, representing a paradigm shift toward resolution-based therapeutics for muscle disorders and optimizing recovery in healthy adults.